Contraception vs CredibleMeds Mobile

The U.S. Medical Eligibility Criteria for Contraceptive Use comprises recommendations for the use of specific contraceptive methods by patients who have certain characteristics or medical conditions. The U.S. Selected Practice Recommendations for Contraceptive Use addresses a select group of common, yet sometimes controversial or complex, issues regarding initiation and use of specific contraceptive methods. The app is developed directly from the CDC Morbidity and Mortality Weekly Report (MMWR) by the Division of Reproductive Health and covers more than 60 characteristics or medical conditions (U.S. MEC) and numerous clinical situations (U.S. SPR). These recommendations are intended to assist healthcare providers when they counsel women, men, and couples about contraceptive method choice and use. Although these recommendations are meant to serve as a source or clinical guidance, healthcare providers should always consider the individual clinical circumstances of each person seeking family planning services.

This CredibleMeds Mobile App supports the CredibleMeds.org website which maintains and posts lists of drugs in categories that reflect their ability to prolong the QT interval on the electrocardiogram and/or cause the life-threatening heart arrhythmia, torsades de pointes (TdP). The CredibleMeds Mobile App was developed for patients with Congenital Long QT Syndrome, healthcare professionals and research scientists in order to provide them with ready access to the most up-to-date version of the CredibleMeds lists of drugs. The App also provides background information on the categories of drug risk and explains the relationship between QT prolongation and TdP. For healthcare professionals and research scientists, the QTdrugs Lists can be used to identify which drugs can cause QT prolongation or TdP. For patients with Congenital Long QT Syndrome, the drugs and risk categories are described and presented separately as the Drugs to Avoid in cLQTS.